Georgetown Lombardi Comprehensive Cancer Center | Strategic Alliance Partners

Latest from Georgetown Lombardi Comprehensive Cancer Center

Trastuzumab Deruxtecan Represents Potential New Second-Line Standard in HER2+ Metastatic Gastric/GEJ Cancer

October 20, 2021

John Marshall, MD, discusses the results of the DESTINY-Gastric02 trial with trastuzumab deruxtecan in patients with HER2-positive gastric/GEJ cancer, the importance of molecular profiling, and future considerations for the antibody-drug conjugate.

The Marshalls Open a Candid Conversation About Cancer

April 01, 2021

The Marshalls go beyond the pages of their new memoir, Off Our Chests: A Candid Tour Through the World of Cancer, to discuss how Liza's diagnosis of triple-negative breast cancer changed their lives and the key messages they hope readers will take from their book.

Off Our Chests: John Marshall, MD, and Liza Marshall Recount Her TNBC Journey

February 15, 2021

John Marshall, MD, and his wife, Liza, recount the challenging journey of Liza's triple-negative breast cancer (TNBC) diagnosis and how John's career as a gastrointestinal oncologist played into the caregiving process. The interview comes ahead of the release of their book, Off Our Chests, which goes further in depth with their experience.

Learning to Tailor Targeted and Immune Therapy in Lung Cancer

December 14, 2020

Faculty of the MedStar Georgetown University Hospital-hosted Institutional Perspectives in Cancer webinar on lung cancer spotlight key advances made with targeted therapies in lung cancer, the ways in which immunotherapy has complicated treatment decisions, and more!